PTC 124 is a promising treatment for muscular dystrophy caused by nonsense mutations

Source: Inpharma, Volume 1, Number 1561, 2006-10-28 , pp. 6-6(1)

Publisher: Adis International

Keywords: Muscular-dystrophy, treatment; PTC-124, adverse reactions; PTC-124, pharmacokinetics; PTC-124, therapeutic use; PTC-Therapeutics; Research-and-development; Trial-result-clinical; Various-toxicities, drug-induced

Document Type: Short communication

Publication date: 2006-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers